89 results on '"Zamboni, W."'
Search Results
2. Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors
3. Carrier-mediated and artificial-cell targeted cancer drug delivery
4. Applications of Hyperbaric Oxygen Therapy in Plastic Surgery
5. Hyperbarer Sauerstoff als Adjuvans in der Therapie der Streptokokken-Myositis
6. EIS Method for the On-Board Evaluation of the Fuel Cell Impedance
7. Numerical study of the DEKF parameter identification capabilities in fuel cell EIS tests
8. Pharmacokinetics (PK) of CRLX101 administered weekly in patients (pts) with advanced solid tumors
9. Loop Orientation and Preisach Modeling in Hysteresis Systems
10. Comparison of state and parameter estimators for electric vehicle batteries
11. Loop orientation and Preisach modeling in hysteresis systems
12. Open-circuit voltage measurement of Lithium-Iron-Phosphate batteries
13. Initial locomotor sensitivity to cocaine varies widely among inbred mouse strains
14. Comparing open-circuit voltage hysteresis models for lithium-iron-phosphate batteries
15. Stability limit analysis for peak-current-controlled Ćuk converter
16. Experimental analysis of open-circuit voltage hysteresis in lithium-iron-phosphate batteries
17. Parameter identification of Li-Po batteries in electric vehicles: A comparative study
18. 126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)
19. Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
20. Stress-Induced Eddy Currents in Magnetostrictive Energy Harvesting Devices
21. Technetium-99m sulfur colloid (TSC) as a phenotypic probe for the pharmacokinetics (PK) and pharmacodynamics (PD) of pegylated liposomal doxorubicin (PLD) in patients (pts) with recurrent epithelial ovarian cancer (EOC).
22. Meta-analysis of the pharmacokinetic variability of liposomal anticancer agents compared with nonliposomal anticancer agents.
23. Cellular function of the mononuclear phagocyte system (MPS) as a phenotypic probe for pegylated liposomal doxorubicin (PLD) pharmacokinetics (PK) in patients with recurrent ovarian cancer.
24. Stability Issues in Peak-Current-Controlled SEPIC
25. Stability Issues in Peak-Current-Controlled SEPIC
26. 24 Factors affecting the pharmacokinetics (PK) and pharmacodynamics (PD) of nanoparticle and nanosomal anticancer agents
27. Symbolic modelling and design of parallel capacitors in dc-dc converters
28. CAD-based capacitors selection for switching regulators
29. Analytical stability boundary for peak-current mode controlled SEPIC
30. The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.
31. Pharmacokinetics (PK) of oxaliplatin (OX) after intraperitoneal (IP) and intravenous (IV) administration in patients with gynecological malignancies.
32. Crosstalk modelling and analysis of interconnects based on carbon nanotubes bundles
33. A unified model for filter capacitor constraints in DC to DC switching converters design
34. Scoring criteria for the selection of capacitors in DC to DC converters design
35. SEPIC design- part I: Inductive damping
36. SEPIC design- part II: Capacitive damping
37. Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
38. A phase II, pharmacokinetic (PK), and pharmacodynamic (PD) study of weekly docetaxel (DOC) in patients with platinum-resistant ovarian cancer
39. Evaluation of the relationship between patient factors and the reduction in clearance of pegylated liposomal doxorubicin
40. Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced solid tumors
41. Phase I and pharmacokinetic (PK) study of IHL-305 (pegylated liposomal irinotecan) in patients with advanced solid tumors
42. Fast Solution of a 3-D Integral Model for the Analysis of ITER Superconducting Coils
43. Drug–virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model
44. Analysis of Multiwall Carbon Nanotubes Using a Three-Dimensional Integral Formulation and a Fluid Model
45. Broad Band Modeling of a Superconducting Magnetic Energy Storage (SMES) Coil
46. Three-Dimensional Electromagnetic Analysis of Cable-in-Conduit Conductors for Fusion Applications
47. Pharmacokinetic (PK) and pharmacodynamic (PD) study of the combination of docetaxel (Doc) and oxaliplatin (Ox) in patients (Pts) with advanced solid tumors
48. A Transmission-Line Model for Full-Wave Analysis of Mixed-Mode Propagation
49. Electromagnetic 3D analysis of an ITER full-size cable-in-conduit conductor sample
50. Frequency-domain modelling of nanoscale electromagnetic devices using a fluid model and an integral formulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.